News

Deal Announcements

Accolade Accepts Strategic Venture Capital

Monday, July 20, 2015 5:32:00 AM PDT | VentureDeal
   Plymouth Meeting, Pennsylvania  --  Healthcare service technology company Accolade has received $22.5 million in strategic venture capital funding.

Accolade has developed a website and service that provides patients with a health assistant to help them with navigating the healthcare system.

Investors in the round included McKesson Ventures and Independence Health Group.

The company said it would enhance its analytics platform with the funding proceeds.

CEO Tom Spann was previously from the Health and Life Sciences practice at Accenture.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1